Seed Media Group

Profile

DrugMonkey is an NIH-funded biomedical research scientist.

PhysioProf is an NIH-funded basic science faculty member at a private medical school.

Recent Comments

Recent Posts

Blog Promotion

Search this blog

Archives

Blogrollin'

Searching for Science

NIH Basics

MDMA:

Repost: MDMA Case Reports

A recent post of Zuska's discusses the pejorative use of "anecdote" to dismiss personal accounts of gender bias. The generic argument will be well familiar to many scientists who are used to sneering at sources of insight that are limited...

Yeah, Yeah, College Kids Take Drugs (snore)....WHAT???!! 75 Arrests?

Perennial Playboy Magazine Top-Ten Party School San Diego State University is in the news following the arrest of some of its students on allegations of illicit drug dealing and drug possession. The San Diego Union Tribune is reporting: Federal agents...

Heart Surgery for Alexander "Sasha" Shulgin

A brief note of best wishes and speedy recovery for Dr. Shulgin. The MAPS recently noted that Alexander "Sasha" Shulgin underwent heart surgery to repair an aortic valve in early April....

Attitudes on Drug Risk 2: Lies to Children

I'm following up on some blogging resulting from a recent post of mine on the effect Len Bias' death (apparently) had on population level perception of the riskiness of trying cocaine. This will verge on the type of link-vomitus that...

Attitudes on Drug Risk: A lesson from the Len Bias fatality

I have a tendency to refer to data from the Monitoring the Future study with some frequency. Unfortunately I've been too lazy to post the critical data figures for your entertainment. Until today DearReader. One example of which I am...

Clinical MDMA Brief (25 Feb 2008)

As a brief update on my posts on the clinical use of MDMA (Part 1, Part 2) I'll note that the MAPS folks are trumpeting the initiation of yet another clinical trial with extra oomph because it is at dear...

Clinical Use of MDMA, Part 2

As a follow to the prior post on MDMA clinical trials, I wanted to delve down into the MDMA dosing specifics. One major problem I have with the MAPS efforts to pursue clinical trials is the expansion of dosing as...

Search All Blogs

Blogs in the Network

Top Five: Readers' Picks

Top Science Stories

powered by SEED - seedmagazine.com